BioSpace News Archive

Single-use bioprocessing systems are disposable equipment and consumables used in research & development as well as commercial production of biologics and metabolites

The global postoperative pain therapeutics market is driven by a large number of surgical procedures performed across the globe.

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting cancers caused by dysregulated gene expression, today announced that it has relocated its corporate operations within the Texas Medical Center in Houston. In addition to new corporate offices, Salarius has opened a new laboratory space in Johnson & Johnson’s JLABS @ TMC where Salarius will pursue internal preclinical research and explore new development

Expanded role of Ms. Stafford as Chairman reflects the Board’s confidence in her leadership of the Company and strategic direction Renowned pharmaceutical executive Robert Ingram retiring as Executive Chair and remaining a member of Board of Directors MORRISVILLE, N.C., July 28, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced an expanded role of Paula Brown Stafford, President and Chief Executive Officer (“CEO”) of Novan, to als

Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not simply manage, disease, today announced the appointment of Michael H. Davidson, MD to its Board of Directors. Dr. Davidson, an industry leader and expert in preventative cardiology and lipidology, is the Founder and Chief Scientific Officer of Corvi

Adastra Pharmaceuticals Inc. today announced it will present a corporate overview at the Private Healthcare Company Virtual Summer Symposium hosted by LifeSci Partners Aug. 4-5 . Adastra is a clinical-stage biotechnology company developing a potent, orally delivered kinase inhibitor that readily crosses the blood brain barrier and p

NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces that during July 2020, the Company retired approximately $3.3 million of debt, strengthening the Company’s balance sheet.

SignPost Cancer Dx Inc., a company developing an advanced molecular diagnostic test to identify invasive breast cancer, is pleased to announce the filing of a provisional patent for the companys lead diagnostic test - BreastDefense. SignPost

Hutchison China MediTech Limited announced that the China National Medical Products Administration has granted Priority Review status to the New Drug Application for savolitinib for the treatment of non-small cell lung cancer with MET Exon 14 skipping mutations.

PCI Broadens Global Clinical Supply-Chain Service Offerings Into Mainland Europe